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Abstract 28 
1  
The potential ecotoxicological effects of mixtures of contaminants in the aquatic 29 
environment are generating a global concern. Benthic invertebrates, such as the crustacean 30 
Gammarus fossarum, are key in the functioning of aquatic ecosystems, and are frequently 31 
used as sentinel species of water quality status. The aim of this work was to study the effects 32 
of a mixture of the most frequently detected surfactants in the bioconcentration kinetics of 33 
two pharmaceuticals in G. fossarum, evaluating their potential enhancing or suppressing 34 
effects. Laboratory exposure experiments for both pharmaceuticals and surfactants 35 
(concentration ratio 1:25) were set up for two individual compounds, the anxiolytic 36 
oxazepam and the antibiotic sulfamethoxazole. Gammarid samples were processed using 37 
microQuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe) extraction. 38 
Pharmaceuticals concentration in the organisms was followed-up by means of nanoliquid 39 
chromatography coupled to tandem mass spectrometry (nanoLC-MS/MS). Results indicated 40 
a similar mode of action of the surfactants in the bioconcentration kinetics of both drugs, 41 
decreasing the accumulation rate in the organism.. Oxazepam showed a higher 42 
accumulation potential than sulfamethoxazole in all cases. Depuration experiments for 43 
oxazepam also demonstrated the high depurative capacity of gammarids, eliminating >50% 44 
of the concentration of oxazepam in less than 6 h. 45 
1. INTRODUCTION 46 
The environmental presence of pharmaceuticals (PhACs) has been studied in detail in the 47 
last two decades, providing enough data to evidence their ubiquity in both terrestrial  and 48 
aquatic ecosystems [1-4]. PhACs are very bioactive molecules, designed to remain active for 49 
long periods of time, even after being metabolized in the organism. In order to keep that 50 
activity, they are generally highly resilient to biodegradation and so their removal during 51 
conventional wastewater treatment is usually incomplete. These results in their regular 52 
entrance onto the aquatic environment via discharge of wastewater effluents, constituting 53 
an ecotoxicological threat to different non-target aquatic organisms that can be exposed 54 
directly or indirectly to these substances [5-8]: directly by the discharge of these pollutants 55 
in wastewater treatment plants (WWTPs) and indirectly by the accumulation  and 56 
biomagnificaction of these PhACs in the foodweb [9]. However, most of the studies have 57 
focused so far in bioaccumulation and toxicity of single PhACs in superior aquatic taxa such 58 
as fish ([10-16]), neglecting the potential effects in inferior taxonomic groups such as benthic 59 
macro and microinvertebrates. In a recent work by Huerta et al., [17], the antiinflamatories 60 
diclofenac and ibuprofen were found in larvae of caddisflies (Hydrosipche sp.) at 61 
concentrations of 183 ng g-1  and 12.4 ng g-1 (dry weight), respectively  In a different study 62 2  
by Grabicova et al. [18], six different PhACs were found also in Hydrosipche sp. in rivers from 63 
the Czech Republic, reaching concentrations of  85  ng g-1 (wet weight, w.w.) in the case of 64 
the antibiotic azithromycin. Bioaccumulation in Erpobdella sp. (larvae of leeches) was also 65 
investigated in this study, and four different PhACs were detected, being diclofenac the 66 
compound found at the highest concentrations, ranging between 12-33 ng g-1 w.w. Recently, 67 
Lagesson et al. [19] reached the conclusion that bottom-living organisms were the main 68 
receivers of PhACs, as they showed the highest PhACs concentrations in their tissues. 69 
Despite the little data available on their bioaccumulation capacity, most of the species 70 
aforementioned are frequently used as sentinel species, as they play a key role in the food 71 
chain and any alteration or loss of some of them could alter or degrade critical ecosystem 72 
processes. For instance, leaf litter detritivores species are responsible for shredding coarse 73 
particulate organic matter (CPOM) and releasing high amounts of nutrients in solution for 74 
other aquatic species such as bacteria, fungi or algae. The freshwater crustacean Gammarus 75 
sp. is one of the most frequently used species in ecotoxicology. They are widespread in 76 
European freshwater ecosystems, their physiology is well known and they are easy to 77 
culture in the laboratory. Furthermore, their role in the food web is key, as they are very 78 
efficient as detritivores,  being able to process up to the 73% of riparian dead leaf inputs in 79 
the water course[20]. Gammarids also constitute themselves a major food source for other 80 
aquatic and terrestrial vertebrates such as fishes, turtles or birds. Despite their high capacity 81 
to accumulate pollutants ([21-23]), they are very sensitive to them and any physiological 82 
changes in the gammarid population may have effects at higher levels of the food chain [24, 83 
25]. 84 
In the last years, however, scientific concern has shifted from the conventional 85 
monitoring studies on the presence of these PhACs and other pollutants in different 86 
environmental compartments towards a broader vision of the problem, considering on one 87 
hand the presence not only of the parent drugs but also of metabolites and transformation 88 
products and their derived potential ecotoxicological effects [2, 26-33] and on the other the 89 
combined effects of the presence of mixtures of different PhACs (with or without other 90 
organic pollutants) and the potential synergetic, antagonistic or cumulative effects derived 91 
[13, 34-38]. Scientific efforts devoted to study mixture toxicity in aquatic environments have 92 
increased noticeably in the last years and had led to the creation and modification of new 93 
chemicals safety regulations, such as the existing European Union regulation REACH 94 
(Registration, Evaluation and Authorization of Chemicals) [39].  95 
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Taking all this into consideration it is very likely that PhACs coexist in the aquatic 96 
environment with other frequently detected pollutants such as perfluorinated compounds 97 
(PFOs), pesticides, flame-retardants or surfactants. The latter are one of the chemicals most 98 
produced and consumed worldwide [40, 41]. Contrary to PhACs, surfactants can be 99 
eliminated during wastewater treatment up to a 90-95% under optimized conditions, and 100 
they usually have low half-life times [42, 43]. However, their input in the receiving waters is 101 
regular, similarly to what happens to PhACs. Aquatic ecosystems are consequently facing a 102 
chronic exposure to both classes of contaminants, despite at low concentrations.  103 
Surfactants show both hydrophilic and hydrophobic properties in their molecular 104 
structure, which gives them the ability to form micelles in solution (once they have reached 105 
a given concentration, the critical micelle concentration, (CMC)). These micellar structures 106 
confer them strong detergency and solubilisation properties that may have effects in other 107 
surrounding molecules. For instance, in soil ecosystems, hydrophobic organic compounds 108 
(HOCs) such as polycyclic aromatic hydrocarbons (PAHs) or perchloroethylene (PCE) can be 109 
solubilized by micelles (hydrocarbon core) and be transferred from soil to the aqueous 110 
pseudo-phase, leading to their desorption from soils. In fact, this remediation of 111 
contaminated soils and aquifer enhanced by surfactants application has become an effective 112 
and common treatment strategy [44]. Other works have also addressed their influence in 113 
the solubility of other hydrophobic compounds such as trichlorobenzene or 114 
dichlorodiphenyltrichloroethane (DDT) [45]. Surfactants, especially non-ionic species, are 115 
also widely used in pesticide formulations to increase their effectiveness in penetrating 116 
through cuticle structures of weeds, crops, and insects in crop fields [46]. In water 117 
ecosystems, it is well known that surfactants increase the water solubility of chemicals, 118 
depending equally on the physico-chemical properties and the nature of both substances. 119 
Recently, Chen et al. proved that the cationic surfactant cetyltrimethylammonium bromide 120 
(CTAB) significantly enhanced the photodegradation rate of triclosan in water, whereas 121 
anionic and neutral surfactants (sodium dodecyl benzene sulfonate, sodium dodecyl sulfate 122 
(SDS) and neutral polyoxyethylene (20) sorbitan monooleate, inhibited it [47]. The same 123 
CTAB, together with other surfactants (Triton X-100 and 4-dodecylbenzene sulfonic acid 124 
(SDBS)) seemed to reduce considerably the toxicity of different nanoparticles against the 125 
freshwater crustacean Daphnia magna, presumably due to the formation of aggregates of 126 
these nanoparticles [48]. On the contrary, other studies confirmed that, in presence of 127 
surfactants, the toxicity of these nanoparticles increased against certain plant species [49]. 128 
Ecotoxicity of surfactants themselves is usually low. Generally, cationic surfactants are more 129 
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toxic against aquatic species (fish, water flea and algae) than anionic surfactants [40]. EC50 130 
values for cationic surfactants range from 0.1 to 10 ppm, whereas those for anionic 131 
formulations are 1 to 50 ppm [46].  132 
All in all, it is obvious that aquatic ecosystems are submitted to a constant 133 
anthropogenic stress, as a wide variety of organic pollutants of very different nature enter 134 
surface waters on a daily basis, overcoming the equilibrium of these ecosystems and their 135 
capacity to neutralize their effects (dilution, in-stream attenuation, biodegradation etc). 136 
Reliable biomonitoring tools are therefore required to follow up the quality status of these 137 
ecosystems.  138 
The aim of this study is to evaluate the influence of the background presence of a 139 
mixture of the most commonly detected surfactants on the bioaccumulation of selected 140 
PhACs in Gammarus fossarum in laboratory experiments. A novel method based on 141 
miniaturized QuEChERS, followed by nanoLC-MS/MS was applied to quantify the 142 
bioaccumulation of both PhACs individually in G. fossarum, allowing discerning 143 
bioconcentration kinetics under different conditions. The antibiotic sulfamethoxazole (SMX) 144 
and the benzodiazepine oxazepam (OXA) were chosen as target compounds, as they are 145 
frequently detected in environmental waters.  146 
 147 
2. MATERIALS AND METHODS 148 
2.1. Chemicals and reagents  149 
Ultra-pure water (18.2 MΩcm) was obtained from a milliQ water system from 150 
Millipore (Saint-Quentin-en-Yvelines, France). HPLC-grade solvents methanol, acetonitrile, 151 
hexane, formic acid and ammonium acetate were obtained from Sigma-Aldrich (Saint-152 
Quentin-Fallavier, France). Analytical standards for sulfamethoxazole (SMX) and oxazepam 153 
(OXA) (purity > 99%) were also purchased from Sigma-Aldrich. Stock standard solutions for 154 
each of the PhACs were prepared individually in MeOH at 1mg mL-1 and stored in the dark at 155 
−20 °C. Solutions at the corresponding working concentrations were prepared accordingly. 156 
The commercial surfactants benzyldodecyldimethylammonium chloride (BDDAC), 157 
benzyldimethyltetradecyl ammonium chloride (BDTAC), cetyl betaïn, lauryl pyridinium, 158 
sodium 2-ethylhexyl sulfate, Triton X-100 and sodium dodecyl sulfate (SDS) were supplied by 159 
Sigma-Aldrich; Stepanquat GA 90 was supplied by Stepan Company (Chassieu, France); 160 
Texapon N 701 S and benzotriazole by BASF (Lyon, France); Incromine SD by Crodarom SAS 161 
5  
(Chanac, France), Comperlan 100 by Cognis (Boussens, France) and the LAS C10-13 mixture 162 
by Marseille soap company (Marseille, France). Stock solutions of the surfactants (200 mg/l) 163 
were prepared in pure water/LC grade methanol (50/50; v/v) and stored at 4°C in the dark. A 164 
mixture containing all the surfactants was prepared at 5 mg L-1 using the appropriate 165 
dilution factor.  166 
Custom QuEChERS salts (500 mg) were obtained from Agilent Technologies (Massy, France), 167 
and contained MgSO4 (61.5 %), NaCl (15.4%), sodium citrate (15.4%) and disodium citrate 168 
sesquihydrate (7.7%). The pH of the salts was 5-5.5 and its purity was > 99.3%.  169 
 170 
2.2. Wastewater sampling  171 
Effluent wastewater was analyzed to fathom out the amounts of surfactants 172 
discharged into the aquatic environment. Composite samples were taken during 4 173 
consecutive days in November 2015 in the wastewater treatment plant (WWTP) of La 174 
Feyssine (Lyon), which receives an average inflow of 66000 m3 day-1 of sewage from the 175 
Lyon peripheral area (capacity of 300,000 equivalent inhabitants). The collected water is first 176 
introduced into one of three Sedipac® 3D (lamellar settling tanks) to remove grease and grit, 177 
then the pre-treated water is forwarded to three biological treatment lines to remove 178 
carbonated pollution via oxygenation and nitrogen pollution via nitrification/denitrification. 179 
Samples were immediately filtered through a 0.7 µm pore size and directly pretreated for 180 
analysis. 181 
 182 
2.3. Test organisms  183 
Gammarids were collected at the beginning of November 2015 in a small affluent of 184 
the Bourbre river located in a pristine site located near the municipality of Bourgoin-Jallieu 185 
(coordinates 45°36'13.9"N, 5°15'31.6" E). Mature individuals were collected and brought to 186 
the laboratory, where they were kept in 30 L aerated tanks filled with groundwater that was 187 
constantly renewed during an acclimatization and stabilization period of 3 weeks. At this 188 
stage, only males were selected and kept in order to avoid potential sensitivity differences 189 
between sexes [50]. Maturity and size homogeneity amongst individuals was also 190 
considered. The light cycle was set to 10 h of light and 14 h of darkness, and the 191 
temperature in the tanks was kept at 12 °C ± 1°C. Gammarids were fed ad libitum with alder 192 
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leaves (Alnus glutinosa) that were collected in an unpolluted site and preconditioned 193 
(rehydrated in groundwater during a week approximately). 194 
 195 
2.4. Experimental set up 196 
Laboratory experiments were carried out in December 2015. Organisms were 197 
exposed to SMX and OXA separatedly (triplicated experiments for each target compound), 198 
with and without background concentration of surfactants; in both cases, three replicates of 199 
20 male gammarids were exposed for 14 days to a concentration of 1 µg L-1 of the 200 
corresponding drug; beakers were filled up with 500 mL of doped groundwater , and the 201 
gammarids were added at the beginning of the experiment. The same procedure was 202 
repeated in paralell, this time adding groundwater doped with a mix of surfactants at a final 203 
concentration of 25 µg L-1. In both cases, the exposed gammarids were fed ad libitum. The 204 
experiments were performed in semi-static conditions to avoid aeration in the beakers and 205 
prevent potential degradation of the contaminants. Therefore, and in order to maintain the 206 
same dissolved oxygen (DO) level in the experiments, solutions were made new and 207 
replaced every day with groundwater previously aerated during 24 h. This procedure also 208 
prevented potential bacterial growth in the beakers and adsorption of the pollutants to the 209 
leaves, contributing to keep the same exposure concentration throughout the experiment. 210 
Doping volumes of SMX and OXA were calculated to have a proportion of MeOH ≤ 0.1 ‰ 211 
(v/v) in the solutions. Two sets of blank controls (without PhACs) were also set up in 212 
triplicates: three with only a background concentration of surfactants and the other three 213 
without it. In the latter case, the same amount of MeOH as in the experiments doped with 214 
PhACs was added. All the beakers were placed in a water bath at 12 °C ± 1°C, and submitted 215 
to the same light cycle as used during the acclimatization period. 216 
2.5. Gammarids and water follow up 217 
During the experimental period, gammarids were collected right before the start of 218 
the experiments (t0), then after 1d, 2d, 7d and 14d (t1, t2, t3 and t4 respectively). Five 219 
individuals were collected at each sampling time for each set of triplicates, immediately 220 
frozen at -80°C and finally lyophilized. In the case of the gammarids sampled from the 221 
surfactants experiments, they were previously rinsed in deionized water during two minutes 222 
before freezing. Individuals from both blank controls were also sampled at t3 and t4 as 223 
quality controls. 224 
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In order to check and confirm the PhACs concentration in the solutions, water was 225 
sampled directly from the beakers and analyzed at t2 and t4. Temperature, DO and pH were 226 
monitored every day during the experiment to check for constant conditions.At the end of 227 
the exposure, the remaining gammarids were transferred to new beakers with groundwater 228 
to evaluate their depuration capacity. They were sampled individually after 6h, 24h and 48h. 229 
 230 
2.6. Analytical methodology 231 
2.6.1. HPLC-MS/MS analysis 232 
Both effluent wastewater samples and water samples from the different 233 
experimental tests were analyzed by means of HPLC-MS/MS, working with an Agilent Series 234 
1200 RRLC system (Agilent Technologies, Massy, France) coupled to a 3200 QTrap (ABSciex®, 235 
Les Ulis, France). For surfactants analysis in effluent wastewaters, samples were pretreated 236 
following the methodology of Bergé et al. [51]. Briefly, SPE extraction was carried out using 237 
cartridges Cunax2 (3 cc, 200 mg). A volume of 200 mL of wastewater was loaded onto the 238 
cartridges, and taken to a final reconstitution volume of 2 mL. Further information on the 239 
methodology is given in the Supplementary Information (SI) (Tables S1 and S2). 240 
Regarding the water samples from the tests to verify the PhAC concentration during 241 
the experimental period, they did not need any pretreatment (SPE) due to the high working 242 
concentration of the PhACs used and the neglectable amount of suspended solids in the 243 
solutions. An Agilent ZORBAX Eclipse Plus C18 column was used (50 x 2.1 mm, 1.8 µm) with a 244 
mobile phase composition of (a) H2O + 0.1% acetic acid and (B) MeOH. The gradient was a 245 
follows: from 10 to 100% (B) in 2 minutes then 100% (B) during 2 minutes and back to initial 246 
conditions in 3 min. The optimization of the MS/MS experimental conditions for SMX and 247 
OXA was performed by direct syringe infusion of standard solutions of the individual 248 
compounds at 10 ng mL-1. Identification of the precursor ions was performed in the full scan 249 
mode by recording mass spectra from m/z 50 to 500. Analyses were performed in the 250 
selected reaction monitoring (SRM) mode, recording two SRM transitions per compound, 251 
one for quantitation and the other for positive confirmation. The MS/MS settings are given 252 
in Table S3 (SI).  253 
2.6.2. Gammarids analyses 254 
Gammarids were pre-treated and analyzed individually, following and adapting the 255 
method developed by Berlioz-Barbier et al. [23]. Briefly, the sample (1 organism) was placed 256 
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in a 2 mL centrifuge tube and ground with two stainless steel grinding balls by means of a 257 
2010 Geno/Grinder (SPEX Sample Prep, Stanmore, UK) for 2 min at 1000 spm. Once the 258 
sample was ready, 500 µL of milliQ water, 500 µL of ACN and 200 µL of hexane were added 259 
to the centrifuge tube, followed by the QuEChERS citrate buffer. Tubes were shaken 260 
vigorously to avoid agglomeration of the salts, then vortexed during 30 sec and then 261 
centrifuged during 2 min (10000 rpm). Afterward, hexane was removed and 400 µL of ACN 262 
were transferred from the tube to an LC vial, evaporated to dryness under a low N2 stream 263 
and finally reconstituted to 120 µL of H2O:ACN:MeOH (70:15:15) for nanoLC-MS/MS 264 
analysis. 265 
2.6.3. NanoLC-MS/MS analysis 266 
Analyses were performed on an Ultimate 3000 nanoLC system (Thermofisher®, 267 
Villebon sur Yvette, France) coupled to a 5500 Qtrap (ABSciex®, Les Ulis, France) equipped 268 
with a Nanospray II interface (nano-ESI) (ABSciex®). Chromatographic separation of SMX and 269 
OXA was achieved by means of an Acclaim C18 PepMap 100 nanocolumn (5cm x 75 µm, 3µm 270 
particle size, 100 Å pore size) preceded by a C18 PepMap 100 µm-pre-column cartridge (5 271 
mm × 300 µm, 5 µm, 100 Å pore size), both from (Thermofisher®). The auto sampler 272 
temperature was fixed at 5 °C and the column oven was set to 40 °C. An injection volume of 273 
1 µL was used in full loop. More information on the methodology can be found elsewhere 274 
[23]. Briefly, the analysis can be divided into two steps. First, a loading step in which the 275 
target compounds are loaded and trapped in the pre-column by means of a loading pump. 276 
The loading solvent used was H2O:ACN:MeOH (96:2:2) at a flow rate of 20 µL min-1. Then, a 277 
separation step when both pre-column and separation column are connected by the switch 278 
of a 10 port-valve (at 1.5 min of the gradient), and the analytes are back-flushed from the 279 
pre-column to the nanoLC column by means of a micropump. The nanoLC flow was 300 nL 280 
min-1. Mobile phases and the gradient used are described in Table S4 in SI. The valve 281 
switches again at the end of the gradient (19 min) and the pre-column is put offline, washed 282 
and equilibrated for the next sample. The micro-pump keeps connected to the analytical 283 
column till the end of the gradient.  284 
The optimization of the MS/MS experimental conditions was performed as indicated 285 
in section 2.6.1. The nano-ESI source parameters were optimized by on-column injection of 286 
the standards into the chromatographic system.  287 
2.6.4. Quantification 288 
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Matrix-matched calibration was used for quantification for both water and biota. For 289 
gammarids analysis, ten calibration points were prepared for each experimental set. A pool 290 
of blank gammarids was used, working with individual samples of 5.5 mg (average weight of 291 
an individual gammarid). Each sample was doped with the corresponding concentration of 292 
the PhAC, ranging between the LOQ and 50LOQ, and extracted following the same 293 
procedure as the experimental samples. 294 
 295 
3. RESULTS AND DISCUSSION 296 
 297 
3.1. Experimental set up 298 
3.1.1. Selection of working concentrations for SMX and OXA 299 
Physicochemical properties of both studied compounds are summarized in Table 1.  300 
Given the high number of publications dealing with PhACs presence in wastewaters and 301 
surface waters, a bibliographic research was carried out in order to know the usual 302 
concentrations detected for SMX and OXA and choose a representative dope level. A 303 
summary is given in Table S5 (SI).  304 
 SMX is one of the most ubiquitous antibiotics, being frequently detected in all water 305 
ecosystems probably due to its solubility and high excretion rates [52-54]. Its environmental 306 
occurrence and fate has been studied intensively due to its potential, even at low 307 
concentrations, to promote antibiotic resistance [55, 56]. Concentrations in urban WWTP 308 
effluents can range from 10 ng L-1 to 650 ng L-1 [52] and up to  8714 ng L-1 in hospital 309 
effluents [57]. In surface waters, average concentrations of 89.2 ng L-1 were detected in the 310 
Ebro river basin in Spain [52], and up to 653 ng L-1 in the Llobregat river mouth [58].  There is 311 
still a huge uncertainty regarding the biodegradability of SMX during wastewater treatment, 312 
considering that published removal rates range from negative values to 100% elimination 313 
[59]. once released in surface waters, its elimination depends on the presence of 314 
appropriate degrading microorganisms. Photodegradation may have a role in its elimination, 315 
but only to a small extent and in the most superficial water layers. 316 
On the other hand, OXA is a psychiatric drug belonging to the group of 317 
benzodiazepines (anxiolytics). It is also the final degradation product of diazepam, one of the 318 
most consumed antidepressant worlwide [60]. Loos et al. [61] found out that oxazepam was 319 
present in the 90% of the 90 effluent samples analyzed in 18 different European countries, 320 
at an average concentration of 162 ng L-1  Similar results were detected by Baker et al. [62] 321 10  
in the UK . Furthermore, it has been demonstrated that OXA is resilient not only to aerobic 322 
and anaerobic biodegradation, but also to photodegradation [60, 63] and so it is likely that 323 
this compound can persist and bioaccumulate in aquatic ecosystems. Klaminder et al. [64] 324 
concluded that OXA could persist in water systems for decades.   325 
The working concentration of both compounds was finally set at 1 µg L-1 to allow the 326 
evaluation of bioaccumulation and also to make possible future metabolite elucidation 327 
analyses.  328 
3.1.2. Selection of working concentrations for surfactants  329 
Levels of surfactants detected in the effluent wastewater sampled are shown in 330 
Table 2. As observed, the concentrations ranged from 0.13 µg L-1 to 34.2 µg L-1. The highest 331 
concentrations corresponded to the anionic surfactants LAS C10-13, specifically to LAS C12 332 
(34.2 µg L-1). Similar and usually higher concentrations in effluent wastewaters are found in 333 
the literature [43, 51]. A working concentration of 25 µg L-1 was finally selected as 334 
representative of a real scenario. 335 
 336 
3.2. Exposure experiments 337 
Only the free dissolved concentration in water of a given compound is bioavailable 338 
and can pass through biological membranes [65]. The use of groundwater in the 339 
experiments, containing negligible amounts of suspended solids, ensured that none of the 340 
spiked drugs were sorbed or bound to these particles, and so all the pollutant was available 341 
for potential bioconcentration in the test organisms. Working at semi-static conditions aided 342 
to renew the media and the available concentration on a daily basis, avoiding any potential 343 
degradation during the 14 d exposure. Furthermore, the information provided in section 344 
3.1.1 also confirms the resilience of both PhACs in water environment in short-term 345 
experiments.  346 
The concentration of both compounds in the water from the different beakers was 347 
measured twice (once per week) during the experiment (Table 3).  Variation between both 348 
weeks was negligible for OXA (0.7%-4.4%) and low for SMX (9.9%-13%).  Other control 349 
parameters such as pH, DO and T were also measured (see S.I., Table S6 ). 350 
Regarding nano-LC-MS/MS analyses, the methodology used allowed the analysis at 351 
individual scale for five gammarids individuals per day of sampling. Inter-individual 352 
variability was estimated as the relative standard deviation (RSD) and is shown in Table S7 353 11  
(SI). No background concentration was detected in any of the individuals from the blank 354 
controls. 355 
3.2.1. Mortality 356 
After one week of exposure, the mortality of gammarids stayed below 30% in both 357 
controls (with and without surfactants). The overall mortality at the end of the experiment 358 
was of 35% of the individuals in the control without surfactants and a 20% in the control 359 
with the surfactants mixture (see Figure 1). Micelles formed by the surfactants may have a 360 
protective function against external conditions for the gammarids; for instance, against the 361 
doped MeOH that was added in both controls to equal the amount of PhACs added in the 362 
rest of the experiments (despite it remained ≤ 0.1 ‰ (v/v) in all the solutions).  363 
Unfortunately, there are currently no standard exposure tests for gammarids. Different 364 
publications put forward a  cut-off level of 10% mortality in the blank controls, as quality 365 
measure [66, 67]. However, it should be taken into account that the exposure conditions in 366 
these papers were different to those in our work; for instance, the exposure was shorter (10 367 
d), the gammarids were not fed, and the species used (Gammarid pulex) and population 368 
origin were completely different. Nevertheless, considering the proposed threshold, 369 
mortality was highly acceptable at least in the control with surfactants after 10 d (11.6%). On 370 
the other hand, for other sensitive crustaceans such as daphnia, test validity is fixed to 20% 371 
of mortality in the controls (for exposures of 7 days, ISO (2008) International Standard 372 
20665). In our experiment, this 20% mortality is reached after 14 days of exposure in the 373 
control with surfactants, but it was reached after only 4 days in the control without 374 
surfactants. This could also be due to a lack of homogeneity of the individuals: differences in 375 
age and degree of maturity (despite the selection was done carefully), tolerance to the 376 
organic matter in the beakers (although the containers were cleaned and refilled daily), or 377 
some errors during the manipulation of the beakers. 378 
In the experiments without surfactants, SMX showed a rapid increase in the 379 
mortality rate, reaching 23% after the first week, and 28% at the end of the experiment, 380 
with an average of 14 survivors out of 20 in each triplicate experiment (no considering the 381 
individuals sampled) (see Figure 1a). The mortality registered in the experiments with OXA 382 
was slightly lower, with a 15% of mortality after a week and a final mortality of 22% at the 383 
end of the experiment (average of 16 survivors in each triplicate). The potential adverse 384 
effects of SMX in the gammarids acted more rapidly than those of OXA during the 14 days of 385 
exposure. To the author´s knowledge, there are no data regarding the ecotoxicity of SMX 386 
against benthic invertebrates.  The most restrictive ecotoxicity values found in the literature 387 12  
are half maximal effective concentrations (EC50) of 27 µg L-1 against blue green algae and up 388 
to 25.2 mg L-1 against daphnids [68]. In both cases, these EC50 values are much higher than 389 
the concentration used in the experiments in this study (1 µg L-1). Regading OXA, its 390 
ecotoxicity is poorly described in the literature. There is only one published study from 1994 391 
by Calleja et al. [69], in which the hazard quotient for this compound was estimated 392 
considering the environmental measured concentrations (MECs), resulting in “unlikely risk”. 393 
More recently, Brody et al. [70] observed behavioural alterations in wild European perch 394 
exposed to1.8 µg L-1of this drug. 395 
In contrast, the mortality rate was higher in both exposure experiments of OXA and 396 
SMX with background concentration of surfactants, and equal to 33.3% in both cases at the 397 
end of the experiments (with an average of 13 survivors out of 20 in each triplicate).  This 398 
could be explained in terms of the additive effect of the background concentration of the 399 
surfactants. As observed in Figure 1b, the mortality was higher in the PhACs doped 400 
experiments than in the corresponding control, more markedly during the second week. It 401 
seems that the extended exposure to surfactants had an effect on the vulnerability of these 402 
organisms to other external factors, in this case SMX or OXA simultaneously present in the 403 
same media. However, this is not reflected in an increased bioconcentration of SMX or OXA 404 
in the organisms (see section 3.3).  405 
3.2.2. Feeding test 406 
Due to the low number of survivors by the end of the experiments, feed tests could 407 
only be carried out in both control experiments (with and without detergents), in order to 408 
check if the background presence of surfactants, independently from the effects of the 409 
studied PhACs, affected the efficiency of gammarids as CPOM shredders. The feeding rate is 410 
frequently used as a sensitive and robust endpoint in bioassays, indicating relevant changes 411 
in the equilibrium of fresh water ecosystems [71]. 412 
At the end of the experiments, the remaining food was removed from the beakers and 10 413 
leaf discs were added in each replicate of the controls. An average of 10 gammarids 414 
remained in the control without surfactants, and 13 in the controls with the surfactant 415 
concentration.  Differences were not very significant, as feeding was only slightly higher in 416 
those controls with a background concentration of surfactants (5.9% higher), which could be 417 
attributed to stress in the organisms (see Figure S1 in SI). 418 
 419 
3.3. Exposure over time and bioconcentration 420 13  
In all the experimental sets, 5 organisms were taken at each sampling time and 421 
analyzed. Detected values were above LOQ in all cases. With the results obtained, kinetic 422 
curves were built by means of the SciDAVIs free software, using the Levenberg-Marquardt 423 
algorithm [72].  424 
3.3.1. Oxazepam 425 
Figure 2 shows the bioconcentration kinetic curves of OXA in the gammarids. In the 426 
experiment without surfactants (exposure 1µg L-1), an increasing trend was observed from 427 
the beginning, which was strong during the first day, going from 0 to an average value of 428 
50.2 ng g-1 after only 24 h. After that, the concentration in the organisms kept accumulating 429 
but at a more moderate pace. At the end of the experiment, the steady state hadn´t been 430 
achieved, and an average concentration of 106 ng g-1 was detected in the organisms. Sordet 431 
et al. [21]carried out a similar experiment with a lower concentration exposure to the drug 432 
(200 ng L-1). This resulted in a much slower bioconcentration process, reaching an average 433 
value of 2.73 ng g-1 after 1 day. It decreased at day 2 (2.03 ng g-1), but kept increasing till day 434 
7 (3.98 ng g-1). Steady state was achieved during the second week, and the bioconcentration 435 
started decreasing from day 14 on. Comparison with this previous study shows that the 436 
capacity of gammarids to accumulate OXA could be proportional to the exposure 437 
concentration. If we look at the kinetic curve estimated in the present study, it seems that 438 
the bioconcentration plateau was reached between day 4 and 6 of exposure. The mortality 439 
associated to that first week of exposure went up to 15%, higher than the mortality 440 
registered from that point till the end of the experiment (from 15% to 22%).   441 
Lagesson et al. [19]found out bioaccumulation concentrations around 10 ng g-1 in different 442 
benthic invertebrates such as Ephemeroptera sp. or Zygoptera sp. in a natural pond spiked 443 
at an initial concentration of 400 ng L-1. Despite the potential decrease in the water 444 
concentration with time, it barely affected the bioaccumulation levels during the length of 445 
the experiment (65 days). 446 
In the experiment with the background concentration of surfactants, the trend was 447 
similar during the first week, reaching body burdens around 74-76 ng g-1. Bioconcentration 448 
of OXA reached 33.7 ng g-1 after one day (compared to the 50 ng g-1 in the experiment 449 
without surfactants). Between days 2 and 7 of the experiment, average concentrations went 450 
from 47.5 ng g-1 to 74.03 ng g-1 (an increase of 55.7%). It correlates with a quick increase in 451 
the mortality during the first week (25% on day 7). Between days 7 and 14, the 452 
bioconcentration decreased a 12%, reaching an average value of 65 ng g-1, suggesting that 453 
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the steady state would have been achieved during the last days of the experiment and after 454 
that, a depuration process would have started. In contrast, mortality was higher during the 455 
first week (25%) and increased during that last week, but a much lower pace, reaching a final 456 
value of 33% of dead individuals. As observed, the body burden of the gammarids in this 457 
case could have been diminished by the presence of surfactants, which seem to decrease 458 
the capacity of gammarids to accumulate this drug.  Contrary to what was expected,  the 459 
presence of surfactants may have some effect on the physiology of gammarids, as mortality 460 
was higher at the end of this experiment but the bioconcentration of OXA was lower (see 461 
Figure 1b and 2b).   462 
 3.3.2. Sulfamethoxazole 463 
Regarding SMX, bioconcentration kinetics followed a different trend (see Figure 3). 464 
In the experiment without surfactants, bioaccumulation was observed from the beginning of 465 
the experiment but at a much slower rate than that of OXA (18 ng g-1 on day 1); it did not 466 
vary on day 2 and then increased during the rest of the experiment, reaching 44.4 ng g-1 467 
after two weeks (see Figure 3a). In this case, the mortality increased rapidly during the first 468 
week, reaching a 23% at day 7, and then increased to a final value of 28% during the second 469 
week (Figure 1a).  470 
In the experiment with surfactants, it can be observed that the average 471 
concentration detected in the organisms was nearly the same from the first day till the end 472 
of the experiment, indicating that the steady state was reached between day 1 and 2 at a 473 
concentration around 9 ng g-1 (see Figure 3b). Mortality reached a 10% on day 3 and 474 
remained stable till day 6 and increasing much more markedly during the second week (see 475 
Figure 1b). As observed with OXA, it seemed that the background presence of the 476 
surfactants mix decreased the bioconcentration rate of the antibiotic but enhanced the 477 
mortality rate throughout the experiment, especially during the second week. These results 478 
diverge with those observed in the experiment with OXA, in which mortality was more 479 
severe during the first week of exposure. Nevertheless, differences in the bioconcentration 480 
amount between OXA and SMX could be attributed to a higher solubility of the antibiotic, 481 
making it less prone to accumulate in the gammarid tissues. This could also explain why the 482 
background presence of surfactants hampered the bioaccumulation of SMX in comparison 483 
with the exposure experiments without that mix (four times fold). 484 
3.3.3. Bioconcentration factor 485 
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The bioconcentration factor (BCF) reflects that capacity of the organism to 486 
accumulate a given compound from the environment, but only through its respiratory and 487 
dermal surfaces (exposure in the diet is excluded) [65]. It can be calculated following 488 
equation 1: 489 
[1] 490 
𝑑𝑑𝑑𝑑𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜
𝑑𝑑𝑑𝑑
= 𝑘𝑘𝑜𝑜𝑜𝑜 × 𝑑𝑑𝑤𝑤(𝑑𝑑)− 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜 × 𝑑𝑑𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜(𝑑𝑑) 
where t is time, Corganism is the concentration in the organism, kin is the uptake rate constant 491 
from the water (mL g-1 d-1), Cw the concentration in the water and kout is the depuration rate 492 
constant (d-1), which gathers different elimination pathways in the organism such as 493 
respiratory surface, fecal egestion, metabolic biotransformation and/or growth dilution [73]. 494 
Kin and kout are given in Table 4 and were estimated by the SciDAVIs software, considering 495 
first order kinetics described with a one-compartment toxicokinetic model [74]. Only when 496 
Corganism and Cw do not change with time, the system has reached the steady state condition 497 
and BCF can be calculated as follows (equation [2]): 498 
 [2] 499 
𝑘𝑘𝑜𝑜𝑜𝑜
𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜
= 𝑑𝑑𝑜𝑜𝑜𝑜𝑜𝑜
𝑑𝑑𝑤𝑤
= 𝐵𝐵𝑑𝑑𝐵𝐵 
 500 
Steady state was reached only in two of the four experiments.  501 
Following the indications from REACH legislation, those compounds with a BCF > 502 
2000 are considered bioaccumulative, and very bioaccumulative if the corresponding BCF > 503 
5000. Despite BCFs are higher for OXA than for SMX, both are far below these threshold 504 
limits established by the UE.  505 
 506 
3.4. Depuration experiments 507 
 508 
 At the end of the exposure experiments, survivors were placed in beakers with 509 
groundwater during 72 hours to evaluate their depuration capacity. The limiting factor in 510 
this case was the number of survivors at the end of each experiment, and the evaluation 511 
could only be carried out after the exposure experiments for OXA without surfactants, with 512 
a total of 6 gammarids in the three bakers.  As shown in Figure 4, depuration of OXA 513 16  
happened quickly, as levels decreased from 105.4 ng g-1 to 50 ng g-1 in barely 6 h, and it was 514 
fully eliminated before 72 h. Data seemed to follow and first order exponential decay. 515 
Only 4 gammarids survived in both SMX experiments, and after only 6 h, no trace of 516 
sulfamethoxazole could be detected. There were no survivors in the experiment with OXA 517 
and surfactants. 518 
 519 
4. CONCLUSIONS 520 
 521 
The structural and functional equilibrium of freshwater ecosystems is currently 522 
compromised by the environmental presence of a large number of organic pollutants which 523 
are being discharged into natural waters on a regular basis. Data on this regard is still 524 
insufficient for a full risk assessment, particularly on the direct or indirect effects of mixtures 525 
of these contaminants in the first trophic levels. Bibliographic research demonstrates that 526 
uptake data available for aquatic organisms is mostly devoted to fish and aquatic plants. 527 
Recent works have shown the bioaccumulation of selected pharmaceuticals in gammarids, 528 
but have not fully addressed their bioconcentration kinetics. This work demonstrates the 529 
highest capacity of gammarids to accumulate OXA than SMX at the same exposure 530 
conditions, even under environmental stress situations such as the background presence of 531 
other contaminants, and also their capacity to quickly eliminate one of these compounds, 532 
OXA, from their tissues. Mortality registered was higher in the exposure experiments with 533 
surfactants ( 33% vs 28% after 14 d). Bioconcentration of OXA was more relevant than that 534 
of SMX in both experiments with and without the presence of surfactants. Further studies 535 
will focus on the gammarids metabolism of the bioconcentrated PhACs, in order to evaluate 536 
to which extent metabolism is key in the elimination of this compounds and which TPs are 537 
generated. 538 
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FIGURE CAPTIONS 804 
Figure 1. Mortality, expressed as a percentage of dead individuals, during the exposure 805 
experiments. A. Exposure experiments without surfactants. B. Exposure experiments with 806 
surfactants. 807 
Figure 2. Bioconcentration curves of oxazepam in Gammarus fossarum sp.  (a)  Exposure 808 
media with oxazepam at 1 µg L-1. (b). Exposure media with surfactants at 25 µg L-1 and 809 
oxazepam at 1 µg L-1. Curves obtained with SciDavies software. 810 
Figure 3. Bioconcentration curves of sulfamethoxazole in Gammarus fossarum sp. (a)  811 
Exposure media with sulfamethoxazole at 1 µg L-1. (b) Exposure media with surfactants at µg 812 
L-1 and sulfamethoxazole at 1 µg L-1. For comparative purposes,  both graphs have been 813 
depicted with the same scale on Y axis. Curves obtained with SciDavies software. 814 
Figure 4. Depuration of oxazepam accumulated in Gammarus fossarum (without 815 
surfactants) over < 72 h. 816 
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Figure 1. Mortality, expressed as percentage of dead individuals, during the exposure experiments. A. Exposure experiments without surfactants. B. Exposure 823 experiments with surfactants. 824 
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Figure 2. Bioconcentration curves of oxazepam in Gammarus fossarum sp.  (a)  Exposure media with oxazepam at 1 µg L-1. (b). Exposure media with surfactants at 835 25 µg L-1 and oxazepam at 1 µg L-1. Curves obtained with SciDavies software. 836  837  838  839  840 
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Figure 3. Bioconcentration curves of sulfamethoxazole in Gammarus fossarum sp. (a)  Exposure media with sulfamethoxazole at 1 µg L-1. (b) 851 Exposure media with surfactants at µg L-1 and sulfamethoxazole at 1 µg L-1. For comparative purposes,  both graphs have been depicted with the 852 same scale on Y axis. Curves obtained with SciDavies software. 853  854 
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 855 
Figure 4. Elimination of oxazepam accumulated in Gammarus fossarum (without surfactants) over < 72 h. 856 
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Table 1. Experimental (*) and predicted physico-chemical properties of the studied pharmaceuticals. 857 
 MOLECULAR  STRUCTURE ELEMENTAL  COMPOSITION CAS  NUMBER MW  (average) SOLUBILITY  (mg/L) Log P 
SULFAMETHOXAZOLE 
 
 
C10H11N3O3S 723-46-6 253.278 
610* 0.89* 
  459 0.79 
     
     
      
OXAZEPAM 
 
 
C15H11ClN2O2 604-75-1 286.713 
179* 2.24* 
  88.1 2.01-2.92 
     
     
      Source: www.drugbank.ca (07/2016) 858 
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Table 2. Surfactant levels determined in wastewater effluent from La Feyssine wastewater treatment plant. LOQs are given in Bergé et al. [39]. 859 
SURFACTANT Day 1 Day 2 Day 3 Day 4 
Benzotriazole 4.80 4.29 3.70 3.03 
Comperlan 100 < loq < loq < loq < loq 
Cetyl Betain 0.41 < loq < loq < loq 
Triton X100 3.03 19.62 2.27 3.21 
Stepanquat GA 90 < loq < loq < loq < loq 
BDDAC 5.24 0.53 0.96 0.37 
BDTAC 7.20 0.13 0.55 < loq 
Lauryl pyridinium 1.52 < loq < loq < loq 
Incromine SD < loq < loq < loq < loq 
Sodium 2-ethylhexyl sulfate < loq < loq < loq < loq 
SDS < loq < loq < loq < loq 
LAS C10 3.69 23.15 21.25 28.20 
LAS C11 < loq 33.75 2.51 19.55 
LAS C12 < loq 34.20 < loq 7.87 
LAS C13 < loq 24.55 < loq < loq 
Texapon N 701 S < loq < loq < loq < loq  860 
Table 3. Measured concentration of the studied pharmaceuticals in the experimental tests (n=3) 861 
  
Day 3 Day 13 
  
C (ng L-1) SDV RSD(%) C (ng L-1) SDV RSD(%) 
SULFAMETHOXAZOLE 
No-surfactants 752.5 107.6 14.3 851.5 44.5 5.2 
Surfactants 755.5 91.1 12.1 830.3 39.6 4.8 
OXAZEPAM 
No-surfactants 1016.7 29.4 2.9 1009.7 22.1 2.2 
Surfactants 955.2 41.9 4.4 997.7 23.5 2.3 
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Table 4.  Uptake and depuration constants (Kin and Kout, respectively) and bioconcentration factor (BCF) estimated by SciDAVIs Software 
  Kin Kout BCF ( L/Kg) 
Oxazepam 
no surfactants 61.5 ± 12.3 0.68 ± 0.15 90.4 
Oxazepam  
surfactants 44.5 ± 6.9 0.62 ± 0.11 71.8 
Sulfamethoxazole 
no surfactants 13.6 ± 5.7 0.26 ± 0.15 52.3 
Sulfamethoxazole 
surfactants 11.8 ± 7.4 0.97 ± 0.67 12.2 
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SUPPLEMENTARY INFORMATION 
 
1. HPLC-MS/MS analysis of surfactants in for effluent wastewater (based on Bergé et 
al. J Chrom A 1450 (2016), 64-75 
  SPE EXTRACTION Briefly, SPE extraction was carried out using cartridges Cunax2 (3 cc, 200 mg). They were conditioned with 8 mL of MeOH, 4 mL of miliQ water water and 4 mL of phosphate buffer (0.1 M at pH = 6). A volume of 200 mL was loaded onto the cartridges, and after that they were washed with 5 mL of phosphate buffer and dried under vacuum for 10 min. Elution was performed separately, first with  2 x 5 mL of ACN and then with 2 x 5 mL of ACN with 5% of NH4OH. Both fractions were collected separately, evaporated to dryness under a gentle N2 stream (45ºC) and reconstituted to 1 mL each, with ACN/H2O (65/35; v/v). Finally, both extracts were put together in one vial. 
HPLC-MS/MS ANALYSIS HPLC-MS/MS analyses were performed with an Agilent 1200 LC system (Massy, France), equipped with a quaternary pump, followed by an API-3200 QTRAP from ABSciex (Les Ulis, France).  ABSciex software Analyst 1.6.1 version was used for data collection and instrument control. Analyses in both positive and negative ionization modes were carried out using an Acclaim Surfactant Plus column (3 µm, 150×3 mm, 3.0 µm) preceeded by an Acclaim surfactant Plus guard-column, (5 µm, 3×10 mm), both from Thermo Fischer (Illkirch, France). The mobile phases were 0.1 M ammonium acetate in Milli-Q water (pH=5.0)(A), Milli-Q water (B) and ACN (C).  The gradient is shown in Table S1. 
Table S1. Elution gradient used for the surfactants analysis. 
t (min) %A %B 
0 70% 30% 
1 70% 30% 
8 15% 85% 
20 15% 85%  The analyses were performed in multiple reaction monitoring (MRM) mode, using the two most abundant transitions, for quantification and confirmation respectively. MRM transitions for the surfactants are given in Table S2.  
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Table S2. MS/MS conditions for the surfactants studied (Bergé et al. J Chrom A 1450 (2016), 
64-75) 
SURFACTANT Ionization mode 
Precursor 
 ion 
[M+H]+ 
MRM 
Transitions RT (m) DP (V) EP (V) CE (V) CXP (V) 
Benzotriazole ESI + 120.1 65 1.7 46 10 23 4 92 46 10 23 4 
BDDAC ESI + 304.2 91.1 2.6 51 12 45 4 212.3 51 12 27 4 
BDTAC ESI + 332.4 91 3.7 46 11 49 4 240.3 46 11 29 4 
Stepanquat 
GA 90 ESI + 402.4 283.3 4.3 56 10.5 31 4 57.1 56 10.5 65 4 
Lauryl 
pyridinium ESI + 248.3 80.1 1.7 66 10.5 33 4 57.1 66 10.5 37 4 
Incromine SD ESI + 369.4 324.4 5.0 46 12 31 4 57.1 46 12 57 4 
Sodium 2-
ethylhexyl 
sulfate 
ESI - 209.2 96.8 7.4 -55 -3 -32 0 79.8 -55 -3 -60 0 
SDS ESI - 265.1 96.9 9.2 -65 -3 -36 -2 79.8 -65 -3 -82 0 
LAS C10 ESI - 297.1 119 9.5 -75 -10 -62 0 184 -75 -10 -38 0 
LAS C11 ESI - 311.1 118.9 9.9 -80 -12 -68 -2 182.8 -80 -12 -48 0 
LAS C12 ESI - 325.1 118.8 9.9 -85 -12 -70 0 182.8 -85 -12 -48 0 
LAS C13 ESI - 339.2 118.9 10.3 -95 -12 -72 0 182.8 -95 -12 -50 0 
Texapon N 
701 S ESI - 293.1 79.8 10.7 -55 -2.5 -100 0 96.2 -55 -2.5 -40 0 
Comperlan 
100 ESI + 244.2 62.1 5.6 31 10 33 4 57.1 31 10 35 4 
Triton X100 ESI + 532.4 89.1 5.4 46 10 41 4 133.1 46 10 33 4 576.4 89 5.4 51 10 47 4 36  
133.1 51 10 33 4 620.5 89 5.3 61 9.5 51 4 133.2 61 9.5 37 4 664.5 89.2 5.2 61 12 51 4 133.1 61 12 37 4 708.5 89.1 5.1 66 10 51 4 133.1 66 10 41 4 
Cetyl Betain ESI + 328.3 104.1 6.6 66 12 31 4 85.1 66 12 35 4  
Table S3. MS/MS optimization setting for the two pharmaceuticals used. SRM: selected reaction monitoring; DP: declustering postential; CE: collision energy; CXP: collision cell exit potential. 
 
Precursor 
 ion 
[M+H]+ 
SRM  
transitions DP(V) CE(V) CXP 
SULFAMETHOXAZOLE 254 156 81 21 12 92 81 35 12 
OXAZEPAM 287 241.1 106 106 29 12 269 23 16 
 
 Nano-LC-MS/MS conditions Both oxazepam and sulfamethoxazole were separated using (A) water with 0.1% of acetic acid and (B) MeOH:ACN:H2O(45:45:10) with 0.1% of acetic acid.   
Table S4. Elution gradient used for oxazepam and sulfamethoxazole analysis in biota. 
t (min) %A %B 
0 90% 10% 
1.5 90% 10% 
7 0% 100% 
15 0% 100% 
15.5 90% 10% 
20 90% 10%   37  
Table S5.  Environmental concentrations found in the literature for sulfamethoxazole and oxazepam. 
  WWTP  effluent Surface  water References 
Sulfamethoxazole 
222 10-79 Gros et al, J Chrom A, 2012 50-650 0,2-35,6 Garcia-Galan et al. Environ Int 2011 10,8-284 - Garcia-Galan et al. Sci Total Environ 2012 55,1-532 - Garcia-Galan et al. Anal Bioanal Chem 2012 36,5-80 - Papageorgiou et al.  Sci Total Environ 2016 10 - Collado et al. Environ Pol, 2014 41-8714* - Santos et al.  Sci Total Environ 2013 19-198 - Gros et al. JCA, 2013 142-280** - Loos et al. Water Res 2013 
Oxazepam 
1190-1700 28-53 Berlioz-Barbier et al, (submitted) 162** - Loos et al. Water Res 2013 80-160** 30-40** Hass et al. Water Res 2012 28-133 11-31 Kosjek et al. Water Res 2012    *: hospital effluents; **: average values 
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Table S6. Measured parameters during the experiment. 
 
Control solvents Control  surfactants Oxazepam 
Oxazepam 
+surfactants Sulfamethoxazole 
Sulfamethoxazole 
+surfactants 
pH 7.73(0.34) 7.7(0.26) 7.9 7.9(0.2) 7.9(0.1) 7.8 
Temperature (ºC) 14.82(0.54) 14.7(1.7) 14.6(0.4) 14.6(1.8) 14.7(0.8) 15.3 
Conductivity (µS/cm) 409.6(0.4) 408.9(0.2) 408.5(0.2) 408.9(0.1) 302.1(0.2) 434 
Dissolved O2 (mg/L) 5.1(7.6) 4.4(3.7) 6.6(2.5) 7(1.5) 6.9(1.3) 5.7 *. Measurements were performed in the morning, right before changing the solutions.   
Table S7.  Inter individual variability (n=5) calculated for SMX and OXA analyses each day of sampling  
Time of  
exposure 
(days) 
OXAZEPAM OXAZEPAM (with surfactants) SMX 
SMX  
(with surfactants) 
1 36.40 36.64 19.00 42.40 
2 17.76 12.52 22.60 20.60 
3 10.30 13.80 36.40 31.80 
4 15.10 15.05 15.00 36.60 
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Figure S1. Feeding tests in the controls, expressed in leaf surface area 2  3 
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